To summarize, one of our most important findings is the bioinformatic analysis-based confirmation that the ATF3/NRF2 signaling pathway regulates ferroptosis in RTECs, which not only refines a novel molecular mechanism of ferroptosis, but also provides a therapeutic target for the future treatment of renal fibrosis. The gene discussed is ATF3; the disease is renal fibrosis.